Achieve Life Sciences, Inc.
ACHV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$40 | -$30 | -$42 | -$33 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $3 | $3 | $2 |
| Change in WC | $2 | -$1 | $0 | $1 |
| Other Non-Cash | $2 | $2 | $1 | $0 |
| Operating Cash Flow | -$30 | -$24 | -$38 | -$29 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$48 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $26 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$22 | -$0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$8 | $0 | $0 | $15 |
| Stock Issued | $56 | $15 | $19 | $21 |
| Stock Repurch. | $0 | -$0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $0 | $0 |
| Financing Cash Flow | $49 | $15 | $19 | $37 |
| Forex Effect | $0 | -$0 | $0 | -$0 |
| Net Chg. in Cash | -$3 | -$9 | -$18 | $7 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16 | $25 | $43 | $36 |
| End Cash | $13 | $16 | $25 | $43 |
| Free Cash Flow | -$30 | -$25 | -$38 | -$29 |